Geneva Biotech is a privately held biotechnology company, based in Geneva, Switzerland. Founded in 2012

Geneva Biotech MultiBacMam™ CRISPR

Intelligent DNA delivery systems

Welcome Guest \\ Login

MultiBacMam™ CRISPR

Technology Description

We are designing baculoviral vectors adapted for CRISPR-based genome engineering. With >100kb DNA cargo capacity they will be the most powerful CRISPR delivery system on the market

Technology Release Q3 2018.


MultiBacMam™ CRISPR Kit 1,149.00€ ENQUIRY


E.coli cell expression

Research Highlights

our r&d View all

Latest News

T-CELL AND B-CELL TRANSDUCTION TECHNOLOGIES Geneva Biotech releases the first efficient non-lentiviral transduction system for immortal T-cells and B-cells. Please ...

View all

Contact Us